May 23, 2025

Sage Therapeutics, Inc. (SAGE) Stock Analysis: Exploring the 24% Potential Upside in Biotech

Sage Therapeutics, Inc. (NASDAQ: SAGE) offers a compelling opportunity for investors within the biotechnology sector, particularly those interested in the development and commercialization of brain health..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: A Biotech with Over 440% Potential Upside

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a promising player in the biotechnology sector, is capturing investor attention with its ambitious gene therapy programs targeting rare and life-threatening..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Navigating Growth in Pediatric Orthopedics with a 72% Upside Potential

OrthoPediatrics Corp. (NASDAQ: KIDS), a key player in the healthcare sector, is making strides in the specialized field of pediatric orthopedic medical devices. As a company..

CeriBell, Inc. (CBLL) Stock Report: Harnessing a Potential 79.61% Upside in the Medical Devices Sector

CeriBell, Inc. (CBLL), a burgeoning player in the healthcare sector, is capturing investor attention with its innovative approach to neurological diagnostics. Based in Sunnyvale, California, this..

Replimune Group, Inc. (REPL) Stock Analysis: An Insight into a Biotech Gem with 141% Upside Potential

Investors with a keen interest in the biotechnology sector will find Replimune Group, Inc. (NASDAQ: REPL) a compelling opportunity. This clinical-stage biotech company is at the..

Pharming Group N.V. (PHAR) Stock Analysis: Unveiling a Potential 188.89% Upside for Investors

Pharming Group N.V. (PHAR), a Netherlands-based biopharmaceutical firm, is capturing investor attention with its promising growth trajectory and strategic collaborations aimed at addressing rare diseases. With..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating Challenges with a 22% Upside Potential

AMN Healthcare Services Inc (NYSE: AMN) has positioned itself as a key player in the healthcare staffing and solutions industry, specializing in providing technology-driven workforce solutions..

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: A Biotech with 153% Potential Upside

Zevra Therapeutics, Inc. (NASDAQ: ZVRA), a burgeoning player in the biotechnology sector, stands out with a significant potential upside of 153.38%, according to the latest analyst..

Inventiva S.A. (IVA) Stock Analysis: Exploring a 247% Potential Upside in the Biotech Sector

Inventiva S.A. (NASDAQ: IVA), a clinical-stage biopharmaceutical company based in France, is capturing investor attention with its promising drug development pipeline and significant potential upside. Specializing..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Unveiling a Potential 347.63% Upside

Anavex Life Sciences Corp. (NASDAQ: AVXL), a clinical-stage biopharmaceutical company based in New York, has captured the attention of investors with its promising drug pipeline targeting..

Altimmune, Inc. (ALT) Stock Analysis: Exploring a Potential 256% Upside in the Biotech Sector

Altimmune, Inc. (NASDAQ: ALT) is a clinical-stage biopharmaceutical company that has caught the eye of investors with its ambitious pipeline and notable potential upside. With a..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Is a 214% Upside Within Reach for This Biotech Innovator?

Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology company, has captured the attention of investors with an eye-catching potential upside of 214.32%. Specializing in precision medicines..

Sonida Senior Living, Inc. (SNDA): An Investor Outlook on Revenue Growth and Potential Upside

Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector, operates within the medical care facilities industry, focusing on providing senior housing and related..

Taysha Gene Therapies (TSHA) Investor Outlook: Exploring a Promising 147% Upside Potential

As Taysha Gene Therapies, Inc. (TSHA) navigates the complex landscape of biotechnology, investors are keenly eyeing its potential for significant growth. With a market capitalization of..

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring a 433% Potential Upside in Biotech

For investors looking to capitalize on the biotech sector’s potential, Upstream Bio, Inc. (NASDAQ: UPB) stands out as a compelling opportunity. With a remarkable 433.48% potential..

Verastem, Inc. (VSTM): A Biotech Stock with Over 110% Potential Upside According to Analyst Ratings

Verastem, Inc. (NASDAQ: VSTM), a development-stage biopharmaceutical company, stands out in the biotechnology sector with its promising pipeline focused on cancer treatment. With a market capitalization..

Definitive Healthcare Corp. (DH) Stock Analysis: Is a 30.99% Upside Worth the Risk?

Definitive Healthcare Corp. (NASDAQ: DH) presents a compelling opportunity for investors intrigued by the intersection of healthcare and technology. Specializing in healthcare commercial intelligence, Definitive Healthcare..

Tilray Brands, Inc. (TLRY) Investor Outlook: Exploring a Potential 189.62% Upside

Tilray Brands, Inc. (NASDAQ: TLRY), a leading lifestyle consumer products company in the healthcare sector, has sparked significant interest among investors due to the potential upside..

Embecta Corp. (EMBC) Stock Analysis: Exploring a 73.73% Potential Upside in Healthcare Innovation

In the dynamic world of healthcare investments, Embecta Corp. (NASDAQ: EMBC) presents a compelling case for investors seeking opportunities in the medical instruments and supplies sector...

COMPASS Pathways Plc (CMPS) Investor Outlook: Exploring a Potential 313% Upside in the Mental Health Revolution

As the healthcare sector continues to evolve, COMPASS Pathways Plc (NASDAQ: CMPS) stands at the forefront of pioneering mental health solutions. With a focus on innovative..

Search

Funds

May 23, 2025

Search

Funds

May 23, 2025

FTSE 100

Funds